The palmitoylethanolamide family: a new class of anti-inflammatory agents?
about
The human serum metabolomeReceptors for acylethanolamides-GPR55 and GPR119The orphan receptor GPR55 is a novel cannabinoid receptorInactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoidsMechanism of carbamate inactivation of FAAH: implications for the design of covalent inhibitors and in vivo functional probes for enzymesOf mice and (wo)men: factors influencing successful implantation including endocannabinoidsA fatty gut feelingStructure-guided inhibitor design for human FAAH by interspecies active site conversionDiscovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory PainPharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: drug-discovery strategiesFatty acid amide hydrolase inhibitors: a patent review (2009-2014)Preclinical Characterization of the FAAH Inhibitor JNJ-42165279Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disordersNeuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's diseasePalmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-αBiosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase DBlockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptorsNon-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels.Genetic manipulation of palmitoylethanolamide production and inactivation in Saccharomyces cerevisiae.From Fertilisation to Implantation in Mammalian Pregnancy-Modulation of Early Human Reproduction by the Endocannabinoid System.Mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase.Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory painUlcerative colitis impairs the acylethanolamide-based anti-inflammatory system reversal by 5-aminosalicylic acid and glucocorticoidsEndogenous molecules stimulating N-acylethanolamine-hydrolyzing acid amidase (NAAA).Functional disassociation of the central and peripheral fatty acid amide signaling systems.Palmitoylethanolamide regulates development of intestinal radiation injury in a mast cell-dependent mannerFunctional analysis of the purified anandamide-generating phospholipase D as a member of the metallo-beta-lactamase family.The N-acylethanolamine-hydrolyzing acid amidase (NAAA).Lauroylethanolamide and linoleoylethanolamide improve functional outcome in a rodent model for strokeLocalization of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) expression in mouse brain: A new perspective on N-acylethanolamines as neural signaling molecules.Dietary triacylglycerol structure and its role in infant nutrition.Anandamide levels fluctuate in the bovine oviduct during the oestrous cycle.Cannabinoids and neuroinflammation.The expanding field of cannabimimetic and related lipid mediators.Metabolite profiling in posttraumatic stress disorder.Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context.Palmitoylethanolamide inhibits glutamate release in rat cerebrocortical nerve terminalsCannabinoid receptors and endocannabinoids: evidence for new players.Changes in N-acylethanolamine Pathway Related Metabolites in a Rat Model of Cerebral Ischemia/Reperfusion.Endocannabinoids and related lipids in blood plasma following touch massage: a randomised, crossover study.
P2860
Q21135549-6ACF35DE-407E-4234-B712-1F4209D3FD41Q24647538-100E1D8B-357D-4D0D-A214-CA6BCB422E24Q24670137-914C1F4B-B1C3-43EC-A9B7-63D3104DAAD0Q24680497-7150B7D9-3C7A-487F-8311-6153E2413EE2Q24680869-32460BF9-C286-4E79-A875-D8900C40907DQ26992063-93A0DDB0-B325-4D37-A139-9A48A9CB7EF5Q26999343-2FF33A25-DF80-4E65-89D9-1AFF3DD866BCQ27651822-AD067DDF-7251-44BD-83FF-8EF8A3B182C7Q27655121-25146ABA-D4AD-4E38-AC03-B57F044BA6D7Q28241318-D51B8B27-156F-44F1-A970-C335522FF7CBQ28267884-F6DE3A46-BDBB-46F8-8B3E-B642EE57B1EBQ28271553-7CF15920-6C1D-47AD-944F-D981F6E230EEQ28285103-ED932C3F-D331-4787-9537-C13C98133610Q28482356-E15E6E6C-6F1E-4CDC-8098-E8A7F6492287Q28568120-DABC2BDB-DD8B-4976-9018-54BBF4250F0FQ28581971-3A0AA56D-787F-4E9A-8057-BA0CD972E31FQ28582567-3CF2A3B8-0D7C-4734-9EC7-E4EF4EE3C9C5Q33348081-C067E122-9984-40A0-9D43-C2CE77A99F94Q33468429-1A26A037-5B1B-4048-8994-B3D786257CDAQ33664729-998F6042-A556-465A-8E2A-A0678CBED267Q34062823-CDF1A1A5-B419-4400-BCD1-27C78E25E325Q34179408-823DA84A-3B78-441E-8B00-9C46F2BFF828Q34291196-F55D7E8F-6D85-4A7F-AFF8-0EFC6C6D21F5Q34292125-D9F1A88F-7AC8-469A-A60C-5F81C7D2B526Q34332678-3D960CD8-89BD-4387-9461-1B5ACE79E9C3Q34422088-7B995970-41AA-4545-802A-45F4B5600E69Q34500986-0F68BC4E-8641-4057-80E8-F7E21F25E85CQ34666056-178734F8-B533-4ED8-86C6-C5300CF3EB95Q34673425-5E7219A9-D27F-4BC2-906F-69A0E9F438DEQ34722804-FA3A676F-8E7B-4D69-8B2B-9511561E05CFQ34955183-BD519EA8-B23A-4611-9B05-1429A8F33B3BQ34973900-3A3B13B4-DDF1-4660-933A-5E2856F8C965Q35046205-188074BA-D0F1-4603-9250-493285484E6DQ35048658-770A91DB-27A1-44DD-B534-A07EAE4921FBQ35200833-C9C72869-C0DF-4DBE-AC06-67C88A85E9C9Q35222716-15555D6F-9AB9-4C4F-A04C-F68E042D63B8Q35381177-E911AE3F-082C-4484-93F9-F4AA14E9A8A3Q35594830-93F247EC-541C-4456-A8E5-9375FC9DAD81Q35688321-E8EBD44F-841C-4D61-911E-D7C9C52A2363Q35792553-13A292F6-7DEF-4643-A813-F908A37081C9
P2860
The palmitoylethanolamide family: a new class of anti-inflammatory agents?
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The palmitoylethanolamide family: a new class of anti-inflammatory agents?
@ast
The palmitoylethanolamide family: a new class of anti-inflammatory agents?
@en
The palmitoylethanolamide family: a new class of anti-inflammatory agents?
@nl
type
label
The palmitoylethanolamide family: a new class of anti-inflammatory agents?
@ast
The palmitoylethanolamide family: a new class of anti-inflammatory agents?
@en
The palmitoylethanolamide family: a new class of anti-inflammatory agents?
@nl
prefLabel
The palmitoylethanolamide family: a new class of anti-inflammatory agents?
@ast
The palmitoylethanolamide family: a new class of anti-inflammatory agents?
@en
The palmitoylethanolamide family: a new class of anti-inflammatory agents?
@nl
P2093
P356
P1476
The palmitoylethanolamide family: a new class of anti-inflammatory agents?
@en
P2093
Christopher J Fowler
Didier M Lambert
Kent-Olov Jonsson
Severine Vandevoorde
P304
P356
10.2174/0929867023370707
P577
2002-03-01T00:00:00Z